Skip to content

A Comparative Study of Safety and Efficacy: Contrast-Enhanced Ultrasound-Guided versus Conventional Ultrasound-Guided Percutaneous Nephrolithotomy for Renal Calculi

A Comparative Study of Safety and Efficacy: Contrast-Enhanced Ultrasound-Guided versus Conventional Ultrasound-Guided Percutaneous Nephrolithotomy for Renal Calculi

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122239
Enrollment
Unknown
Registered
2026-04-10
Start date
2023-12-21
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Calculi

Interventions

Intervention group:Percutaneous nephrolithotomy (PCNL) guided by renal pelvis contrast-enhanced ultrasonography
Control group:PCNL guided by conventional ultrasonography.

Sponsors

The First Medical Center of the Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Diagnosis of renal calculi confirmed by abdominal radiography (KUB), ultrasonography,or urological CT, with stone diameter >= 2 cm, multiple renal calculi, or staghorn calculi; 3. The target renal calyx is non-dilated, or mild hydronephrosis is diagnosed (manifested on ultrasound as normal renal parenchymal thickness and echogenicity, normal renal volume, separation of the collecting system by 1.5-3 cm, with O-shaped or C-shaped anechoic areas visible within the renal sinus); 4. Provision of signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Preoperative or intraoperative evidence of hydronephrosis. 2. Presence of unmanageable urinary tract infection, sepsis, or pyelonephritis. 3. Complex calculi requiring multi-tract access. 4. Bilateral proximal ureteral or bilateral renal calculi. 5. History of previous ipsilateral PCNL. 6. Calculi associated with anatomical anomalies (e.g., calculi in solitary kidney, duplex kidney, duplex renal pelvis, horseshoe kidney, or medullary sponge kidney). 7. Coexistent renal tumor. 8. Patients deemed unfit for surgery due to significant cardiac, cerebral, pulmonary, or other comorbidities. 9. Patients unable to maintain the prone position due to severe spinal deformity or obesity. 10. Contraindications to ultrasound contrast agents (e.g., right-to-left cardiac shunts, known hypersensitivity to contrast agents). 11. Pregnant or lactating women. 12. Concurrent participation in another clinical trial.

Design outcomes

Primary

MeasureTime frame
The first puncture success rate;

Secondary

MeasureTime frame
Puncture time;Channel establishment time;Postoperative hospital stay;time of operation;Residual stone rate;

Countries

China

Contacts

Public ContactMai Haixing

The First Medical Center of the Chinese PLA General Hospital

574709550@qq.com+86 134 6636 6606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026